TABLE 2.
HERITABILITY ESTIMATES
Phenotypes | NHW |
AA |
Wald P Value* | ||
---|---|---|---|---|---|
N | Heritability (SE) | N | Heritability (SE) | ||
FEV1, % predicted† |
6,128 |
38.4% (5.7%)‡ |
2,756 |
50.9% (13.5%)‡ |
0.395 |
FEV1/FVC† |
6,128 |
37.3% (5.7%)‡ |
2,756 |
46.6% (13.9%)‡ |
0.538 |
Log of % emphysema |
5,777 |
28.2% (6.0%)‡ |
2,514 |
31.3% (14.5%)‡ |
0.849 |
Log of % gas trapping |
5,385 |
24.0% (6.4%)‡ |
2,192 |
27.9% (14.9%)‡ |
0.808 |
COPD disease status† |
4,929 |
37.7% (7.4%)‡ |
2,152 |
37.9% (20.4%) |
0.992 |
Body mass index |
6,145 |
18.7% (6.0%) |
2,792 |
29.0% (12.8%) |
0.469 |
Height | 6,145 | 59.4% (5.6%)‡ | 2,792 | 45.5% (13.5%)‡ | 0.341 |
Definition of abbreviations: AA = African American; COPD = chronic obstructive pulmonary disease; NHW = non-Hispanic white.
Wald test for the comparison of heritability estimation between NHW and AA.
After ascertainment adjustment, heritability of FEV1 is still 38.4% and FEV1/FVC is 37.0% in NHW. In the AA population the adjusted heritability of FEV1 is 51.0% and FEV1/FVC is 49.4%.
LRT P value for testing heritability different from zero passed threshold 0.05.